GSK3B and early-onset autosomal dominant Alzheimer disease: Several methods have been used to design and synthesize a series of derivatives, aiming at simultaneously regulating neuronal calcium channels and GSK-3β to produce effective targets for the treatment of Alzheimer's disease [21].